Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions
Yubai Zhou(University of North Carolina at Chapel Hill), Xiaodong Wang(University of North Carolina at Chapel Hill), Kenneth H. Pearce(University of North Carolina at Chapel Hill), Anutosh Chakraborty(University of Florida), Huanchen Wang(National Institute of Environmental Health Sciences), Michael A. Stashko(University of North Carolina at Chapel Hill), Molee Chakraborty(Saint Louis University), Guangning Zong(National Institute of Environmental Health Sciences), Sandip Mukherjee(Saint Louis University), Daowei Huang(University of North Carolina at Chapel Hill), Chunfang Gu(National Institute of Environmental Health Sciences), Stephen B. Shears(National Institutes of Health)
Cited by 31
Related Papers
Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13
|Cell|2011|817
Adipocyte-specific deletion of Ip6k1 reduces diet-induced obesity by enhancing AMPK-mediated thermogenesis
|Journal of Clinical Investigation|2016|87